SELLAS Life Sciences Group, Inc. Conversion of Stock, Shares Converted
SELLAS Life Sciences Group, Inc. (SLS) reported Conversion of Stock, Shares Converted of 659.53 thousand shares for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2018-08-14
- SELLAS Life Sciences Group, Inc. conversion of stock, shares converted for the quarter ending 2018-06-30 was 345.30K shares.
- SELLAS Life Sciences Group, Inc. conversion of stock, shares converted for the quarter ending 2018-03-31 was 314.23K shares, a 93.01% decline year-over-year.
- SELLAS Life Sciences Group, Inc. conversion of stock, shares converted for the quarter ending 2017-09-30 was 3.31M shares.
- SELLAS Life Sciences Group, Inc. conversion of stock, shares converted for the quarter ending 2017-06-30 was 0.00 shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month |
|---|---|---|---|
| 2018-06-30 | 345.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 659.53K shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 314.23K shares 10-Q · filed 2018-05-15 | ||
| 2017-09-30 | 3.31M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 3.31M shares derived: sum of 2 quarters · filed 2017-11-09 | 7.81M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 4.50M shares 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 4.50M shares 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |